For example, in NSCLC, TS expression may influence sensitivity to pemetrexed (Fig. 6), though its predictive value remains under investigation.150,151 Circulating mRNA biomarkers have shown potential to predict outcomes and may facilitate real-time monitoring of therapeutic response.152,153. This evidence concerns the gene TYMS and non-small cell lung carcinoma.